RHO and rheumatoid arthritis: FOXM1 is highly expressed in RA models, and FOXM1 may reduce the expression of RND3, activate the Rho/ROCK pathway, and promote the growth and inflammation of fibroblast-like synovial cells (RA-FLSs) [104].